Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Spire Healthcare Group plc S00 | 41 | Elevated | Healthcare | United Kingdom | 5 / 6 | $1.3B |
| AMN Healthcare Services Inc AMN | 59 | Elevated | Healthcare | United States | 4 / 6 | $1.3B |
| SHIP HEALTHCARE HLDG.INC. 5EZ | 38 | Normal | Healthcare | Japan | 5 / 6 | $1.3B |
| Integra Lifesciences Holdings Corp IART | 85 | Acute | Healthcare | United States | 4 / 6 | $1.3B |
| ChemoMetec A/S CHEMM | 27 | Normal | Healthcare | Denmark | 5 / 6 | $1.3B |
| Artivion Inc AORT | 47 | Elevated | Healthcare | United States | 5 / 6 | $1.3B |
| Immatics N.V IMTX | 74 | Stretched | Healthcare | Germany | 5 / 6 | $1.3B |
| MeiraGTx Holdings plc MGTX | 49 | Elevated | Healthcare | United States | 5 / 6 | $1.3B |
| Nutex Health Inc NUTX | 7 | Contained | Healthcare | United States | 4 / 6 | $1.3B |
| UNIPHAR PLC EO -08 0NR | 38 | Normal | Healthcare | Ireland | 5 / 6 | $1.3B |
| Pennant Group Inc PNTG | 29 | Normal | Healthcare | United States | 5 / 6 | $1.3B |
| Spire Healthcare Group Plc SPI | 43 | Elevated | Healthcare | United Kingdom | 5 / 6 | $1.3B |
| Certara Inc CERT | 50 | Elevated | Healthcare | United States | 4 / 6 | $1.3B |
| Cronos Group Inc CRON | 46 | Elevated | Healthcare | Canada | 4 / 6 | $1.2B |
| Mannkind Corp MNKD | 37 | Normal | Healthcare | United States | 4 / 6 | $1.2B |
| Summerset Group Holdings Ltd SNZ | 47 | Elevated | Healthcare | New Zealand | 4 / 6 | $1.2B |
| Procept BioRobotics Corp PRCT | 49 | Elevated | Healthcare | United States | 5 / 6 | $1.2B |
| CVS Group Plc CVSG | 30 | Normal | Healthcare | United Kingdom | 5 / 6 | $1.2B |
| Monte Rosa Therapeutics Inc GLUE | 48 | Elevated | Healthcare | United States | 5 / 6 | $1.2B |
| GoodRx Holdings Inc - Class A GDRX | 50 | Elevated | Healthcare | United States | 4 / 6 | $1.2B |
| PHC HOLDINGS CORP. 2GY | 50 | Elevated | Healthcare | Japan | 5 / 6 | $1.2B |
| TOWA PHARMA. CO. 6QC | 37 | Normal | Healthcare | Japan | 5 / 6 | $1.2B |
| Odyssey Therapeutics, Inc. ODTX | 66 | Stretched | Healthcare | United States | 5 / 6 | $1.2B |
| Avanos Medical Inc AVNS | 69 | Stretched | Healthcare | United States | 4 / 6 | $1.2B |
| U.S. Physical Therapy Inc USPH | 32 | Normal | Healthcare | United States | 5 / 6 | $1.2B |
| Teladoc Health Inc TDOC | 65 | Stretched | Healthcare | United States | 4 / 6 | $1.2B |
| Ryman Healthcare Limited RH70 | 69 | Stretched | Healthcare | New Zealand | 4 / 6 | $1.1B |
| Staar Surgical Company STAA | 91 | Acute | Healthcare | United States | 4 / 6 | $1.1B |
| Maravai LifeSciences Holdings Inc - Class A MRVI | 91 | Acute | Healthcare | United States | 4 / 6 | $1.1B |
| INVENTIVA S.A.(PROM.)-01 6IV | 75 | Stretched | Healthcare | France | 5 / 6 | $1.1B |
| Kura Oncology Inc KURA | 61 | Stretched | Healthcare | United States | 5 / 6 | $1.1B |
| Lumexa Imaging Holdings Inc LMRI | 57 | Elevated | Healthcare | United States | 4 / 6 | $1.1B |
| Janux Therapeutics Inc JANX | 66 | Stretched | Healthcare | United States | 5 / 6 | $1.1B |
| Iradimed Corp IRMD | 23 | Normal | Healthcare | United States | 5 / 6 | $1.1B |
| Clinica Baviera CBAV | 21 | Normal | Healthcare | Spain | 3 / 6 | $1.1B |
| Opko Health Inc OPK | 60 | Stretched | Healthcare | United States | 5 / 6 | $1.1B |
| Luye Pharma Group Ltd LUP | 47 | Elevated | Healthcare | China | 5 / 6 | $1.1B |
| Kuros Biosciences AG KURN | 31 | Normal | Healthcare | Switzerland | 5 / 6 | $1.1B |
| CureVac N.V. CVAC | 11 | Contained | Healthcare | Germany | 5 / 6 | $1.0B |
| ALPHAMAB ONCOLO.DL-000002 3NK | 50 | Elevated | Healthcare | China | 5 / 6 | $1.0B |
| Pacira BioSciences Inc PCRX | 41 | Elevated | Healthcare | United States | 4 / 6 | $1.0B |
| Avalo Therapeutics Inc AVTX | 59 | Elevated | Healthcare | United States | 3 / 6 | $1.0B |
| Castle Biosciences Inc CSTL | 45 | Elevated | Healthcare | United States | 5 / 6 | $1.0B |
| Arbutus Biopharma Corp ABUS | 63 | Stretched | Healthcare | United States | 4 / 6 | $1.0B |
| Lexicon Pharmaceuticals Inc LXRX | 52 | Elevated | Healthcare | United States | 5 / 6 | $1.0B |
| Medincell SA MEDCL | 32 | Normal | Healthcare | France | 5 / 6 | $1.0B |
| Gubra A/S GUBRA | 17 | Contained | Healthcare | Denmark | 5 / 6 | $990M |
| Basilea Pharmaceutica AG BSLN | 22 | Normal | Healthcare | Switzerland | 5 / 6 | $986M |
| QuidelOrtho Corporation QDEL | 78 | Stretched | Healthcare | United States | 4 / 6 | $986M |
| Modern Dental Group Limited 1MD | 23 | Normal | Healthcare | Hong Kong | 5 / 6 | $974M |
| Inventiva IVA | 75 | Stretched | Healthcare | France | 5 / 6 | $972M |
| Amphastar Pharmaceuticals Inc AMPH | 41 | Elevated | Healthcare | United States | 5 / 6 | $958M |
| Geron Corp GERN | 64 | Stretched | Healthcare | United States | 4 / 6 | $957M |
| SIHUAN PHARMACE TEL1 | 44 | Elevated | Healthcare | Hong Kong | 5 / 6 | $957M |
| VYNE Therapeutics Inc VYNE | 40 | Elevated | Healthcare | United States | 5 / 6 | $953M |
| Wave Life Sciences Ltd WVE | 47 | Elevated | Healthcare | United States | 5 / 6 | $947M |
| Vetoquinol VETO | 41 | Elevated | Healthcare | France | 5 / 6 | $946M |
| Ardelyx Inc ARDX | 54 | Elevated | Healthcare | United States | 5 / 6 | $942M |
| Bioventus Inc - Class A BVS | 38 | Normal | Healthcare | United States | 5 / 6 | $931M |
| CanSino Biologics Inc CJH | 38 | Normal | Healthcare | China | 5 / 6 | $922M |
| Ceribell Inc CBLL | 52 | Elevated | Healthcare | United States | 5 / 6 | $917M |
| Adlai Nortye Ltd ANL | 78 | Stretched | Healthcare | United States | 4 / 6 | $914M |
| Beta Bionics Inc BBNX | 44 | Elevated | Healthcare | United States | 5 / 6 | $897M |
| Synsam AB SYNSAM | 34 | Normal | Healthcare | Sweden | 5 / 6 | $894M |
| ABBISKO CAYMAN DL-00001 8ZD | 19 | Contained | Healthcare | China | 5 / 6 | $890M |
| Theravance Biopharma Inc TBPH | 17 | Contained | Healthcare | United States | 5 / 6 | $884M |
| Talkspace Inc TALK | 38 | Normal | Healthcare | United States | 4 / 6 | $871M |
| MEDCAP AB SK-40 61MA | 15 | Contained | Healthcare | Sweden | 3 / 6 | $866M |
| Rigel Pharmaceuticals RIGL | 19 | Contained | Healthcare | United States | 5 / 6 | $861M |
| Inmode Ltd INMD | 46 | Elevated | Healthcare | Israel | 5 / 6 | $860M |
| Oxford BioMedica PLC OXB | 62 | Stretched | Healthcare | United Kingdom | 5 / 6 | $858M |
| MENICON CO.LTD 5FR | 42 | Elevated | Healthcare | Japan | 5 / 6 | $852M |
| SI-BONE Inc SIBN | 43 | Elevated | Healthcare | United States | 5 / 6 | $850M |
| Healthstream Inc HSTM | 46 | Elevated | Healthcare | United States | 4 / 6 | $849M |
| BML Inc BMZ | 46 | Elevated | Healthcare | Japan | 5 / 6 | $847M |
| Aclaris Therapeutics Inc ACRS | 79 | Stretched | Healthcare | United States | 3 / 6 | $846M |
| Anteris Technologies Global Corp AVR | 77 | Stretched | Healthcare | Australia | 5 / 6 | $839M |
| Genfit S.A. GNFT | 57 | Elevated | Healthcare | France | 5 / 6 | $835M |
| Dynavox Group DYVOX | 32 | Normal | Healthcare | Sweden | 4 / 6 | $826M |
| SAFILO GROUP SFL.MI | 41 | Elevated | Healthcare | Italy | 5 / 6 | $825M |
| Pharming Group NV PHARM | 29 | Normal | Healthcare | Netherlands | 4 / 6 | $822M |
| Advanced Medical Solutions Group plc AQA | 23 | Normal | Healthcare | United Kingdom | 5 / 6 | $822M |
| Esperion Therapeutics Inc ESPR | 35 | Normal | Healthcare | United States | 4 / 6 | $819M |
| DBV Technologies DBVT | 57 | Elevated | Healthcare | France | 5 / 6 | $818M |
| Pharming Group N.V. PHAR | 30 | Normal | Healthcare | Netherlands | 5 / 6 | $813M |
| Collegium Pharmaceutical Inc COLL | 22 | Normal | Healthcare | United States | 5 / 6 | $800M |
| Arjo AB (publ) ARJO-B | 41 | Elevated | Healthcare | Sweden | 4 / 6 | $792M |
| Varex Imaging Corp VREX | 59 | Elevated | Healthcare | United States | 4 / 6 | $779M |
| 4D Molecular Therapeutics Inc FDMT | 46 | Elevated | Healthcare | United States | 4 / 6 | $779M |
| Akso Health Group AHG | 82 | Acute | Healthcare | China | 4 / 6 | $771M |
| Phathom Pharmaceuticals Inc PHAT | 71 | Stretched | Healthcare | United States | 5 / 6 | $766M |
| AdaptHealth Corp AHCO | 49 | Elevated | Healthcare | United States | 5 / 6 | $762M |
| Phreesia Inc PHR | 31 | Normal | Healthcare | United States | 5 / 6 | $755M |
| China Shineway Pharmaceutical Group Limited C1S | 38 | Normal | Healthcare | China | 5 / 6 | $753M |
| CytomX Therapeutics Inc CTMX | 50 | Elevated | Healthcare | United States | 5 / 6 | $732M |
| CK Life Sciences Int'l. (Holdings) Inc LSI | 64 | Stretched | Healthcare | Hong Kong | 5 / 6 | $724M |
| SOPHiA Genetics SA SOPH | 53 | Elevated | Healthcare | Switzerland | 5 / 6 | $715M |
| LIFETECH SCI.DL-00000125 81X | 42 | Elevated | Healthcare | China | 5 / 6 | $709M |
| Enhabit Inc EHAB | 46 | Elevated | Healthcare | United States | 5 / 6 | $707M |
| Shattuck Labs Inc STTK | 49 | Elevated | Healthcare | United States | 5 / 6 | $706M |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.